One of the world's leading biotechnology companies, Genzyme is dedicated
to making a major positive impact on the lives of people with serious
diseases. Since its founding in 1981, the company has introduced
breakthrough treatments across several areas of medicine that have
provided new hope for patients. Today, approximately 10,000 Genzyme
employees serve patients in nearly 100 countries.
Genzyme's products are focused on rare genetic diseases, multiple
sclerosis, cardiovascular disease, and endocrinology. The company's
commitment to innovation continues today with a substantial development
program focused on these fields, as well as other areas of unmet medical
need.
